Page last updated: 2024-10-25

debrisoquin and Hyperventilation

debrisoquin has been researched along with Hyperventilation in 1 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Hyperventilation: A pulmonary ventilation rate faster than is metabolically necessary for the exchange of gases. It is the result of an increased frequency of breathing, an increased tidal volume, or a combination of both. It causes an excess intake of oxygen and the blowing off of carbon dioxide.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bialkowska, M1
Zajac, D1
Mazzatenta, A1
Di Giulio, C1
Pokorski, M1

Reviews

1 review available for debrisoquin and Hyperventilation

ArticleYear
Inhibition of peripheral dopamine metabolism and the ventilatory response to hypoxia in the rat.
    Advances in experimental medicine and biology, 2015, Volume: 837

    Topics: Adaptation, Physiological; Animals; Blood Pressure; Carotid Body; Catechol O-Methyltransferase; Cate

2015
chemdatabank.com